ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 18,500 shares, a decrease of 38.1% from the December 15th total of 29,900 shares. Currently, 2.7% of the shares of the company are short sold. Based on an average daily volume of 84,300 shares, the days-to-cover ratio is presently 0.2 days.

ReShape Lifesciences Stock Performance

RSLS traded down $0.34 during trading on Tuesday, hitting $4.66. The stock had a trading volume of 42,334 shares, compared to its average volume of 31,639. ReShape Lifesciences has a twelve month low of $4.09 and a twelve month high of $29.00. The company’s 50-day moving average price is $5.05 and its 200 day moving average price is $7.57.

ReShape Lifesciences Company Profile

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.